HK1060118A1 - (S)-4-amino-5-chloro-2-methoxy-n-Ä1-Ä1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide for treating gastrointestinal motility disorders. - Google Patents

(S)-4-amino-5-chloro-2-methoxy-n-Ä1-Ä1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide for treating gastrointestinal motility disorders.

Info

Publication number
HK1060118A1
HK1060118A1 HK04102812A HK04102812A HK1060118A1 HK 1060118 A1 HK1060118 A1 HK 1060118A1 HK 04102812 A HK04102812 A HK 04102812A HK 04102812 A HK04102812 A HK 04102812A HK 1060118 A1 HK1060118 A1 HK 1060118A1
Authority
HK
Hong Kong
Prior art keywords
piperidinylübenzamide
piperidinylmethylü
tetrahydrofuryl
carbonyl
chloro
Prior art date
Application number
HK04102812A
Other languages
English (en)
Inventor
Shiro Kato
Hiroshi Yamazaki
Yoshimi Hirokawa
Yoko Kan
Naoyuki Yoshida
Kazuo Morikage
Yukiko Morikage
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of HK1060118A1 publication Critical patent/HK1060118A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04102812A 2002-05-16 2004-04-22 (S)-4-amino-5-chloro-2-methoxy-n-Ä1-Ä1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide for treating gastrointestinal motility disorders. HK1060118A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002141262 2002-05-16

Publications (1)

Publication Number Publication Date
HK1060118A1 true HK1060118A1 (en) 2004-07-30

Family

ID=29267809

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102812A HK1060118A1 (en) 2002-05-16 2004-04-22 (S)-4-amino-5-chloro-2-methoxy-n-Ä1-Ä1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide for treating gastrointestinal motility disorders.

Country Status (27)

Country Link
US (1) US6696468B2 (da)
EP (1) EP1362857B1 (da)
JP (1) JP3643107B2 (da)
KR (1) KR20040107520A (da)
CN (1) CN1653063A (da)
AR (1) AR040021A1 (da)
AT (1) ATE273304T1 (da)
AU (1) AU2003230245A1 (da)
BR (1) BR0309933A (da)
CA (1) CA2483368A1 (da)
CZ (1) CZ20041084A3 (da)
DE (1) DE60300021T2 (da)
DK (1) DK1362857T3 (da)
ES (1) ES2227500T3 (da)
HK (1) HK1060118A1 (da)
HU (1) HUP0501016A2 (da)
IL (1) IL165012A0 (da)
MX (1) MXPA04011332A (da)
NO (1) NO20045469L (da)
PL (1) PL372724A1 (da)
PT (1) PT1362857E (da)
RU (1) RU2004136853A (da)
SK (1) SK50192004A3 (da)
TR (1) TR200403020T2 (da)
TW (1) TW200400186A (da)
WO (1) WO2003097638A1 (da)
ZA (1) ZA200409053B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
JP5042028B2 (ja) * 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
ES2523851T3 (es) * 2005-03-02 2014-12-02 Theravance Biopharma R&D Ip, Llc Compuestos de quinolinona como agonistas de los receptores 5-HT4
US7256294B2 (en) * 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
US20080200505A1 (en) * 2005-05-27 2008-08-21 Astrazeneca Ab Piperidines for the Treatment of Chemokine Mediated Diseases
TW200722419A (en) * 2005-05-27 2007-06-16 Astrazeneca Ab Chemical compounds
EP2402316A1 (en) 2005-07-21 2012-01-04 AstraZeneca AB (Publ) Piperidine derivatives
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
US8546416B2 (en) 2011-05-27 2013-10-01 Novartis Ag 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
EP2852591A1 (en) 2012-05-03 2015-04-01 Novartis AG L-malate salt of 2, 7 - diaza - spiro [4.5]dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111472A (ja) 1996-04-30 1999-01-06 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びそれを含有する医薬組成物
ES2234248T3 (es) 1998-04-28 2005-06-16 Dainippon Pharmaceutical Co., Ltd. Derivados de 1-(1-sustituido-4-piperidinil) metil)-4-piperidina, procedimiento de produccion de estos; composiciones medicinales que contienen estos compuestos e intermediarios de estos compuestos.
JP2000080081A (ja) 1998-06-24 2000-03-21 Dainippon Pharmaceut Co Ltd １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物
JP2001122784A (ja) 1999-10-27 2001-05-08 Dainippon Pharmaceut Co Ltd １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬

Also Published As

Publication number Publication date
DE60300021D1 (de) 2004-09-16
EP1362857B1 (en) 2004-08-11
CA2483368A1 (en) 2003-11-27
TW200400186A (en) 2004-01-01
US6696468B2 (en) 2004-02-24
DK1362857T3 (da) 2004-12-20
US20030216433A1 (en) 2003-11-20
PT1362857E (pt) 2004-11-30
JP3643107B2 (ja) 2005-04-27
BR0309933A (pt) 2005-02-09
NO20045469L (no) 2005-02-16
JP2004043453A (ja) 2004-02-12
WO2003097638A1 (en) 2003-11-27
AU2003230245A1 (en) 2003-12-02
RU2004136853A (ru) 2005-06-27
PL372724A1 (en) 2005-07-25
AR040021A1 (es) 2005-03-09
IL165012A0 (en) 2005-12-18
CN1653063A (zh) 2005-08-10
EP1362857A1 (en) 2003-11-19
ES2227500T3 (es) 2005-04-01
SK50192004A3 (sk) 2005-04-01
CZ20041084A3 (cs) 2005-02-16
TR200403020T2 (tr) 2005-05-23
DE60300021T2 (de) 2005-09-08
HUP0501016A2 (en) 2006-02-28
ZA200409053B (en) 2005-07-12
KR20040107520A (ko) 2004-12-20
MXPA04011332A (es) 2005-02-14
ATE273304T1 (de) 2004-08-15

Similar Documents

Publication Publication Date Title
HK1060118A1 (en) (S)-4-amino-5-chloro-2-methoxy-n-Ä1-Ä1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide for treating gastrointestinal motility disorders.
ZA200304940B (en) Gaming apparatus.
ZA200304941B (en) Gaming apparatus.
HK1061480A1 (en) Level adjustment apparatus.
AP2210A (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain.
ZA200303940B (en) Gaming apparatus.
SG116536A1 (en) Scrambler circuit.
IL173835A0 (en) Compositions useful for treating gastrointestinal motility disorders
MXPA03006607A (es) Metodo combinado para tratar trastornos dependientes de hormonas.
GB0212638D0 (en) Authentication means
GB0201015D0 (en) Hydrocarbon treating
GB0217737D0 (en) Oil well treatment
ZA200409489B (en) Treatment for diabetes.
AU2003248679A8 (en) Treating disease using radium-225
ZA200304369B (en) Colon hydrotheraphy apparatus.
ZA200300341B (en) Fingerprint apparatus.
EG23241A (en) Beshob.
ZA200308116B (en) Telemetry apparatus.
TWI319226B (en) Bumping process
AU3515P (en) OHB00-37.90 Bracteantha bracteata
TJ393B (en) Method of substitution end-defects of the lower jaw.
ZA200303379B (en) Energiser.
ZA200307942B (en) Hand washing apparatus.
ZA200306866B (en) Matches.
ZA200408169B (en) Imidazolinylmethyl aralkylsulfonamides.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090103